Investing.com - Verona Pharma ADR (NASDAQ: VRNA) reported third quarter EPS of $-0.020, better than the analyst estimate of $-0.030. Revenue for the quarter came in at $0.00 versus the consensus estimate of $0.
Verona Pharma ADR's stock price closed at $14.280. It is down -28.350% in the last 3 months and up 15.460% in the last 12 months.
Verona Pharma ADR saw 0 positive EPS revisions and 3 negative EPS revisions in the last 90 days. See Verona Pharma ADR's stock price’s past reactions to earnings here.
According to InvestingPro, Verona Pharma ADR's Financial Health score is "fair performance".
Check out Verona Pharma ADR's recent earnings performance, and Verona Pharma ADR's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar